These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28212443)

  • 1. Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
    Barasch N; Gong X; Kwei KA; Varma S; Biscocho J; Qu K; Xiao N; Lipsick JS; Pelham RJ; West RB; Pollack JR
    PLoS One; 2017; 12(2):e0171265. PubMed ID: 28212443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.
    Andreasen S; Varma S; Barasch N; Thompson LDR; Miettinen M; Rooper L; Stelow EB; Agander TK; Seethala RR; Chiosea SI; Homøe P; Wessel I; Larsen SR; Erentaite D; Bishop JA; Ulhøi BP; Kiss K; Melchior LC; Pollack JR; West RB
    Am J Surg Pathol; 2019 Apr; 43(4):489-496. PubMed ID: 30520817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
    Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
    Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP; Jo VY; Hornick JL
    Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade transformation of acinic cell carcinoma: an inadequately treated entity?
    Chintakuntlawar AV; Shon W; Erickson-Johnson M; Bilodeau E; Jenkins SM; Davidson JA; Keeney MG; Rivera M; Price DL; Moore EJ; Olsen KD; Kasperbauer JL; Foote RL; Price KA; García JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):542-549.e1. PubMed ID: 27017401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
    Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
    Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
    Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
    Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma.
    Lee DY; Brayer KJ; Mitani Y; Burns EA; Rao PH; Bell D; Williams MD; Ferrarotto R; Pytynia KB; El-Naggar AK; Ness SA
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: Role of NOR-1 (NR4A3) immunohistochemistry.
    Meiklejohn K; Hrones M; Wang M; Prasad ML; Cai G; Adeniran A; Gilani SM
    Cytopathology; 2023 May; 34(3):219-224. PubMed ID: 36825365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
    Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
    Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gene fusion detection methods in salivary gland tumors.
    Sun L; Petrone JS; McNulty SN; Evenson MJ; Zhu X; Robinson JA; Chernock RD; Duncavage EJ; Pfeifer JD
    Hum Pathol; 2022 May; 123():1-10. PubMed ID: 35183572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
    Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are acinic cell carcinomas of the breast and salivary glands distinct diseases?
    Piscuoglio S; Hodi Z; Katabi N; Guerini-Rocco E; Macedo GS; Ng CK; Edelweiss M; De Mattos-Arruda L; Wen HY; Rakha EA; Ellis IO; Rubin BP; Weigelt B; Reis-Filho JS
    Histopathology; 2015 Oct; 67(4):529-37. PubMed ID: 25688711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.
    Weinreb I; Zhang L; Tirunagari LM; Sung YS; Chen CL; Perez-Ordonez B; Clarke BA; Skalova A; Chiosea SI; Seethala RR; Waggott D; Boutros PC; How C; Liu FF; Irish JC; Goldstein DP; Gilbert R; Ud Din N; Assaad A; Hornick JL; Thompson LD; Antonescu CR
    Genes Chromosomes Cancer; 2014 Oct; 53(10):845-56. PubMed ID: 24942367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Acinic Cell Carcinoma with SYN2::PPARG Fusion.
    Dimbleby G; Rettino A; Jogai S; Harinayanan S; Patel N; Battison S; Moutasim K
    Head Neck Pathol; 2024 Oct; 18(1):107. PubMed ID: 39417931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
    Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
    Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
    Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
    Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.